Oncology and Therapy

Published by Adis, Springer Healthcare

Open access · CC BY-NC · In DOAJ · United Kingdom · Lung Cancer Treatments and Mutations

Journal at a glance

ISSN

2366-1070

Publisher

Adis, Springer Healthcare

Country

United Kingdom

Language

en

License

CC BY-NC

Also known as: Oncol Ther (Abbreviation)

Indexing

• Scopus: Indexed
• DOAJ: Active
• Pubmed: Active

Metrics

Subjects

• Lung Cancer Treatments and Mutations
• Cancer Immunotherapy and Biomarkers
• Cancer survivorship and care
• HER2/EGFR in Cancer Research
• Multiple Myeloma Research and Treatments
• Lung Cancer Research Studies
• Advanced Breast Cancer Therapies
• Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
• Internal medicine

Articles on PubPorta

The most recent records PubPorta holds for this journal.

• Ceralasertib Plus Durvalumab in Chinese Patients with Advanced Solid Tumors: A Nonrandomized Clinical Trial (2026)
• Clinicians’ Perspectives on the Impact of Different Attributes of Androgen Receptor Pathway Inhibitors on Prostate Cancer Treatment Preferences and Compliance in Mexico (2026)
• A Comprehensive Mapping of Real-World Studies and Data Sources for Oncology in China: Insights into Landscape, Challenges, and Future Direction (2026)
• IMMPACT-MM: Insights into Multiple Myeloma Patient Outcomes following Early-Line Cilta-cel Treatment (2026)
• Podcast on the Emerging Role of PD-(L)1/VEGF Bispecific Antibodies in the Evolving Advanced Renal Cell Carcinoma Treatment Landscape (2026)

Similar journals

• Future Oncology — United Kingdom · — · Same subject: Cancer Immunotherapy and Biomarkers, Same subject: HER2/EGFR in Cancer Research, 4 shared subjects in total, Same country
• ESMO Open — Kingdom of the Netherlands · Open access · Same subject: Advanced Breast Cancer Therapies, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total, Same language
• Cancer Medicine — United Kingdom · Open access · Same subject: Cancer Immunotherapy and Biomarkers, Same subject: Cancer survivorship and care, 3 shared subjects in total, Same country, Same language
• Anti-Cancer Drugs — United Kingdom · — · Same subject: HER2/EGFR in Cancer Research, Same subject: Lung Cancer Research Studies, 3 shared subjects in total, Same country, Same language
• Oncologist — United Kingdom · Open access · Same subject: Cancer Immunotherapy and Biomarkers, Same subject: HER2/EGFR in Cancer Research, 3 shared subjects in total, Same country
• npj Breast Cancer — United States · Open access · Same subject: Advanced Breast Cancer Therapies, Same subject: Cancer Immunotherapy and Biomarkers, 3 shared subjects in total, Same language

Sources: DOAJ, OpenAlex, NLM Catalog, Crossref, Scopus · Last verified 2026-09-05

Journal homepage · Author guidelines